Welcome to our dedicated page for Albemarle Corporation news (Ticker: $ALB), a resource for investors and traders seeking the latest updates and insights on Albemarle Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Albemarle Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Albemarle Corporation's position in the market.
Albemarle and Martin Marietta Materials have signed an innovative agreement to utilize limestone material from Albemarle's Kings Mountain Mine in a socially and environmentally responsible manner. The agreement aims to support local communities and reduce operational footprints while contributing to sustainable resource management. Albemarle plans to deliver limestone material to Martin Marietta's Kings Mountain Quarry for processing and sale as construction aggregate, with royalty fees benefiting local initiatives.
Albemarle (NYSE: ALB) has declared a quarterly dividend of $0.40 per share with an annualized rate of $1.60. The dividend will be payable on July 1, 2024, to shareholders of record as of June 14, 2024.
Albemarle reported its first quarter 2024 results, with net sales of $1.4 billion driven by energy storage volume growth. The company achieved net income of $2 million and adjusted diluted EPS of $0.26. They also delivered over $90 million in productivity and restructuring cost savings in Q1 and reaffirmed their FY 2024 corporate outlook. Albemarle's CEO highlighted the team's agility in market conditions, emphasizing their focus on profitable organic growth and value creation.